SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-032643
Filing Date
2022-03-11
Accepted
2022-03-11 07:10:43
Documents
14
Period of Report
2022-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228946d1_8k.htm   iXBRL 8-K 26139
2 EXHIBIT 99.1 tm228946d1_ex99-1.htm EX-99.1 120685
6 GRAPHIC tm228946d1_ex99-1img01.jpg GRAPHIC 7649
  Complete submission text file 0001104659-22-032643.txt   345610

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lptx-20220311.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20220311_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20220311_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm228946d1_8k_htm.xml XML 3708
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 22731112
SIC: 2834 Pharmaceutical Preparations